Eu medical device post market surveillance. Our services also include EU A...

Eu medical device post market surveillance. Our services also include EU Authorized Representative support and preparation of post-market surveillance documentation. Starting from May 28, 2026, the use of the first four modules is mandatory: 1 day ago · CE marking on a medical device means the manufacturer has demonstrated that the product meets EU safety, health, and performance requirements and can be legally sold throughout the European Economic Area (EEA). Discover which representative type your business needs for European market access. Mar 1, 2026 · Corporations that manufacture, distribute, or market medical devices are responsible for post-market surveillance (PMS) under both UK and EU/US regulations. Fully applicable from May 26, 2022, introducing stricter requirements for clinical evidence and post-market surveillance. The European Commission confirmed that the following four modules are fully functional, triggering mandatory use. Mar 3, 2026 · The EU Medical Device Regulation (MDR 2017/745) replaced the previous directive system with significantly more rigorous requirements for clinical evidence, post-market surveillance, and device traceability. The IVDR requires manufacturers to conduct continuous post-market surveillance (PMS) to track how their devices perform in real-world use. Mar 2, 2026 · Why EUDAMED Is Becoming Mandatory The European Commission has confirmed that EUDAMED will become fully mandatory from 28 May 2026 for medical device and IVD manufacturers operating under MDR (EU) 2017/745 and IVDR (EU) 2017/746. 5 days ago · The regulation has introduced stricter requirements for device safety, clinical evaluation, post-market surveillance, and traceability. The majority of documents on this page are endorsed by the Medical Device Coordination Group (MDCG) in accordance with Article 105 of the MDR and Article 99 of the IVDR. Increased Notified Body involvement. Essential Duties and Responsibilities:. Jan 8, 2026 · The European Commission’s Medical Device Coordination Group (MDCG) has outlined the postmarket surveillance (PMS) requirements that medical device and in vitro diagnostic makers should adhere to as part of their quality management system (QMS). Key Regulatory Frameworks UK: Medical Devices Regulations 2002 (UK MDR 2002, amended 2020), aligned with EU MDR 2017/745. Jan 30, 2026 · Overview of EU post market surveillance requirements for medical devices and in vitro diagnostic medical devices, including PMS systems, reporting obligations, and regulatory oversight under MDR and IVDR. Dec 19, 2018 · Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 (IVDR) on in vitro diagnostic medical devices. For higher-risk devices (Class C and D), manufacturers must produce Periodic Safety Update Reports summarizing the data they have collected and any actions taken as a result. The letters “CE” stand for Conformité Européenne, and the mark is mandatory for medical devices sold in the EU. Post market surveillance processes and activities are mainly related to Complaint Investigations, Medical Device / Vigilance reporting, metrics monitoring and supporting external audits/inspections. 3 days ago · The IVDR is the EU regulation governing in vitro diagnostic medical devices, replacing the previous In Vitro Diagnostic Directive (IVDD). 1 day ago · Learn the key differences between Swiss Rep and EU Rep services for medical device compliance. EUDAMED is designed to improve transparency, traceability, and regulatory oversight across the EU medical device market. Dec 19, 2025 · MDCG 2025–10: Guidance on post-market surveillance of medical devices and in vitro diagnostic medical devices (December 2025) 4 days ago · The EU medical device IVD market will see mandatory EUDAMED implementation on 28 May 2026. From 28 May 2026, EUDAMED stops being optional and becomes a legal obligation for all manufacturers under the EU MDR and IVDR. Stronger clinical/performance evaluation Manage a post-market surveillance team that executes the complaint investigation process for devices. MDCG 2025-10 Guidance on post-market surveillance of medical devices and in vitro diagnostic medical devices The introduction of the post-market surveillance (PMS) requirement under the Medical Devices Regulation (MDR) requires a more consistent, standardized and systematic review of all PMS data by manufacturers. Jan 31, 2023 · While market surveillance is conducted by the EU competent authorities, post-market surveillance is the process by which manufacturers ensure the continued safety and performance of a medical device or IVD. It is also required to introduce post-market mon-itoring frameworks for detecting anomalous behaviours and security breaches in real-time and ensuring data-driven medical devices remain secure Feb 19, 2026 · EUDAMED is composed of six modules related to: actor registration, unique device identification (UDI) and device registration, notified bodies and certificates, clinical investigations and performance studies, vigilance and post-market surveillance and market surveillance. Our team has many years of experience working with medical device manufacturers and helping them obtain CE certification while maintaining full regulatory compliance. Understanding the requirements is essential to your ability to provide the European Union market with safe medical devices that perform as intended and comply with the Regulations.